BORTEZOMIB Accord subst sèche 3.5 mg flac

7680674810025 CH-67481 L01XG01 07.16.1.

Reimbursement limitations:

BORTEZOMIBAC

Substitution préparation originale/générique
Aucune nouvelle garantie de prise en charge n'est nécessaire pour le traitement …

BORTEZOMIB Accord subst sèche 3.5 mg flac
BORTEZOMIB Accord subst sèche 3.5 mg flac
BORTEZOMIB Accord subst sèche 3.5 mg flac
1 / 3
google

Details

Product number
6748102
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
bortezomibum 3.5 mg, mannitolum, pro vitro.

Articles (1)

Bortezomib Accord 3.5 mg, Pulver zur Herstellung einer lnjektionslösung
Pulver
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
07/03/2025
Professional SmPC
Français
07/03/2025
Professional SmPC
Italien
07/03/2025

Detailed composition

Substance Quantity Type Category
(N/A)
3.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 421.85
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/12/2020

Authorization holder

Accord Healthcare AG

4103 Bottmingen

Authorization information

Swissmedic authorization number
67481
Drug name
Bortezomib Accord, Pulver zur Herstellung einer lnjektionslösung
Galenic form
PULPA
ATC Code
L01XG01
Authorization status
Z
Dispensation category
A
First authorization
06/03/2020
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
Multiples Myelom

Packaging details

Description (FR)
BORTEZOMIB Accord subst sèche 3.5 mg flac
Description (DE)
BORTEZOMIB Accord Trockensub 3.5 mg Durchstf
Market launch
06/03/2020
Narcotic (BTM)
No

Original drug

Velcade, Lyophilisat zur Herstellung einer Injektionslösung
CHF 460.10
View original

Other packaging sizes

BORTEZOMIB Accord subst sèche 1 mg flac
1 DUR
View